Walleye Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.09M Sell
22,500
-20,500
-48% -$6.11M 0.03% 681
2025
Q4
$14.2M Sell
43,000
-10,500
-20% -$3.56M 0.04% 438
2025
Q3
$18.5M Sell
53,500
-81,800
-60% -$24.7M 0.07% 280
2025
Q2
$42.2M Buy
135,300
+102,800
+316% +$39.3M 0.16% 75
2025
Q1
$17M Sell
32,500
-84,300
-72% -$43.1M 0.08% 252
2024
Q4
$59.1M Buy
116,800
+37,800
+48% +$21.5M 0.14% 88
2024
Q3
$46.2M Sell
79,000
-52,300
-40% -$29.6M 0.1% 132
2024
Q2
$66.9M Sell
131,300
-19,800
-13% -$9.7M 0.12% 91
2024
Q1
$74.7M Buy
151,100
+107,900
+250% +$54.9M 0.13% 84
2023
Q4
$22.7M Buy
43,200
+5,000
+13% +$2.67M 0.05% 282
2023
Q3
$19.3M Sell
38,200
-1,000
-3% -$492K 0.05% 275
2023
Q2
$18.8M Buy
39,200
+34,800
+791% +$17M 0.07% 187
2023
Q1
$2.08M Buy
4,400
+1,300
+42% +$627K 0.03% 697
2022
Q4
$1.64M Buy
3,100
+2,500
+417% +$1.32M 0.03% 690
2022
Q3
$303K Buy
+600
New +$315K 0.01% 1833

Other funds holding UNH

Walleye Capital's UNH Position: Q1 2026 in Review

Walleye Capital reduced its UnitedHealth (UNH) stake by 12% in Q1 2026, selling an estimated $4.74M and leaving 113,214 shares worth $30.6M. The position accounts for 0.13% of the portfolio, ranked #93.

Walleye Capital first reported a position in UNH in Q3 2018 and has held it in 12 quarters since. The position peaked at $42.6M in Q4 2025. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Walleye Capital held 113,214 shares of UnitedHealth worth $30.6M as of Q1 2026.
  • Walleye Capital sold 15,905 UnitedHealth shares in Q1 2026, an estimated $4.74M.
  • UnitedHealth made up 0.13% of Walleye Capital's portfolio in Q1 2026, its #93 holding.
  • Walleye Capital first reported a position in UnitedHealth in Q3 2018 and has held it in 12 quarters since.
  • Walleye Capital's UnitedHealth position peaked at $42.6M in Q4 2025.
  • 3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.